Find the derivative of the Vector Function  ,  when t=1.  

A 30-year-old woman with moderate atopic dermatitis (eczema) presents for follow-up. She has failed topical corticosteroids due to skin atrophy and now asks about starting tacrolimus ointment. She is otherwise healthy, with normal vitals and no systemic immunosuppressant use. When counseling this patient, which major long-term safety concern should the NP emphasize? 

A 55-year-old man with metastatic prostate cancer and painful vertebral lesions is started on zoledronic acid infusions to reduce skeletal-related events. His medications include leuprolide for androgen deprivation and calcium/vitamin D supplements. Two weeks after his first infusion, he reports perioral tingling and muscle cramps. On exam, he has a positive Chvostek’s sign. Which laboratory parameter is most important to monitor in this patient? 

A 30-year-old woman presents with nasal congestion, clear rhinorrhea, and itchy eyes during springtime. She has no fever or systemic illness. Which treatment is first-line for allergic rhinitis? 

A 62-year-old man with diabetes and CAD is prescribed sildenafil for ED. Which concurrent medication is an absolute contraindication? 

A 62-year-old man presents with acute monoarticular pain, swelling, and redness in the left knee that began overnight. He reports a history of recurrent gout and is on allopurinol 200 mg daily with good adherence. He also takes furosemide for heart failure. Joint aspiration reveals needle-shaped, negatively birefringent crystals. Serum uric acid today is 6.8 mg/dL (previously >10). Which is the most appropriate management of this acute flare? 

A 67-year-old man hospitalized with COPD exacerbation is treated with high-dose IV steroids. The NP plans to taper steroids after recovery. Why is tapering required? 

A 42-year-old woman with systemic lupus erythematosus presents for follow-up. She has been taking hydroxychloroquine for the past 6 months with partial symptom relief. Labs today show persistent proteinuria and elevated anti-dsDNA titers. The NP considers escalating therapy. Which pharmacologic agent is the most appropriate next step? 

A 70-year-old woman with postmenopausal osteoporosis is unable to tolerate oral alendronate due to severe esophagitis despite appropriate administration (upright posture, fasting intake). Her history includes stage 3 chronic kidney disease (eGFR 45 mL/min) and prior vertebral compression fracture. She continues calcium and vitamin D supplementation. Which pharmacologic alternative is most appropriate for secondary fracture prevention? 

A 55-year-old woman presents with severe hot flashes and night sweats that significantly impair sleep. She has a past medical history of unprovoked deep vein thrombosis (DVT) at age 50, hypertension controlled on lisinopril, and obesity (BMI 32). She underwent a total abdominal hysterectomy for fibroids 8 years ago. She asks about starting hormone replacement therapy (HRT) because her sister found relief with oral estrogen. Her labs show normal renal and liver function. Which is the most appropriate evidence-based management for this patient’s vasomotor symptoms?